Global Urinalysis Market Moving at Growth Rate of 7.6% Between 2016 to 2020

The urinalysis market, by test type, is classified into biochemical urinalysis and sediment urinalysis. Global urinalysis systems market is categorized on the basis of product, test type, application, end user, and region. The urinalysis systems market is expected to reach $1,286 million by 2019 from $892 million in 2014, at a CAGR of 7.6%. The disease diagnostics segment is expected to register the highest growth rate in the urinalysis systems market, by application, during the forecast period. Rising incidence of chronic disease such as diabetes and increasing number of researches conducted to develop new tests using urinalysis for early and better diagnosis of HIV and cancer are driving growth of this market.

Key players in the urinalysis market include Alere Inc. (Acon Labs) (U.S.), ARKRAY Inc. (Japan), Bio-Rad (U.S.), Danaher (Iris International) (U.S.), E77 Eletronika (Hungary), Mindray (China), Roche Diagnostics (Switzerland), Siemens Healthcare (Germany), Sysmex (Japan), and Urit Medical (China) amongst others.

Complete report of 68 market data tables & 88 figures spread through 150 pages and in-depth TOC on "Urinalysis Market" at http://www.reportsnreports.com/reports/354105-urinalysis-market-by-product-dipstick-reagent-urine-analyzer-poc-test-type-biochemical-sediment-microscopic-application-diagnosis-diabetes-uti-kidney-disease-pregnancy-end-user-hospital-research-institute-home-forecast-to-2019.html .

Relatively untapped markets of Asian region and high adoption rate of point-of-care urinalysis devices have opened an array of opportunities for urinalysis systems market. However, the lower adoption rate of fully automated systems in less developed economies and low awareness regarding kidney diseases, diabetes and urinary tract infections in developing economies are expected to restrain the growth of this market. The Asian region and point-of-care devices are expected to serve as new revenue pockets for the urinalysis market in the coming five years.

Implementation of the Affordable Care Act (ACA) in U.S. which necessitates hospitals to perform frequent urinalysis tests to keep a check on hospital acquired infections is a major factor driving urinalysis market. Furthermore, government support in form of funding, increasing incidences of diabetes, colossal pool of elderly population, and technological advancements are other factors driving the growth of this market.

Click here for more discount on this  http://www.reportsnreports.com/contacts/discount.aspx?name=354105 .

The urinalysis market, by test type, is classified into biochemical urinalysis and sediment urinalysis. The sediment urinalysis segment is further divided into microscopic urinalysis and flow cytometric urinalysis. The sediment urinalysis segment is expected to witness the highest growth in the forecast period due to technological advancements.

Urinalysis market by application is divided into disease diagnosis and pregnancy test. The disease diagnosis segment is further subdivided into urinary tract diseases, kidney diseases, diabetes, and others. The disease diagnosis application is expected to witness the highest growth in the forecast period due to rising prevalence of various chronic diseases.

Single user license, a sample copy of “Urinalysis Market by Product (Dipstick, Reagent, Urine Analyzer, POC), Test Type (Biochemical, Sediment, Microscopic), Application (Diagnosis, Diabetes, UTI, Kidney Disease, Pregnancy), End User (Hospital, Research Institute, Home) - Forecast to 2019” research report can be requested at http://www.reportsnreports.com/contacts/requestsample.aspx?name=354105 .

About Us:

ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets.

Contact:Priyank TiwariUNIT no 802, Tower no. 7, SEZMagarpatta city, HadapsarPune - 411013Maharashtra, India.Tel:  +1-888-391-5441sales@reportsandreports.com